Cargando…
Evaluation of Delcath Systems’ Generation 2 (GEN 2) Melphalan Hemofiltration System in a Porcine Model of Percutaneous Hepatic Perfusion
PURPOSE: A new melphalan hemoperfusion filter (GEN 2) was evaluated in a simulated-use porcine model of percutaneous hepatic perfusion (PHP). The current study evaluated melphalan filtration efficiency, the transfilter pressure gradient, and the removal of specific blood products. MATERIALS AND METH...
Autores principales: | Moeslein, Fred M., McAndrew, Elizabeth G., Appling, William M., Hryniewich, Nicole E., Jarvis, Kevin D., Markos, Steven M., Sheets, Timothy P., Uzgare, Rajneesh P., Johnston, Daniel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024156/ https://www.ncbi.nlm.nih.gov/pubmed/24402644 http://dx.doi.org/10.1007/s00270-013-0826-5 |
Ejemplares similares
-
Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan
por: de Leede, Eleonora M., et al.
Publicado: (2017) -
Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan
por: de Leede, Eleonora M., et al.
Publicado: (2017) -
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
por: Meijer, T. Susanna, et al.
Publicado: (2019) -
Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis
por: Bai, JunYuan, et al.
Publicado: (2022) -
Isolated hepatic perfusion in the pig with TNF-alpha with and without melphalan.
por: Borel Rinkes, I. H., et al.
Publicado: (1997)